Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

37.60 -0.23 (-0.61%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income
The risk of a dividend cut is minimal, and the yield of this stock is favorable. 
Via The Motley Fool
MarketBeat Week in Review – 5/22 - 5/26
The debt ceiling standoff and inflation continue to fight for investors’ attention as we head into what is historically a quieter period for the markets 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy Interest Rates
3 No-Brainer Stocks to Buy for Under $100 Right Now
These stocks might not remain under $100 for too much longer. 
Via The Motley Fool
Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected
Like Pfizer and Novo Nordisk, Eli Lilly is also testing an oral GLP-1 in weight loss. 
Via Investor's Business Daily
Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex
Smokeless Tobacco Treatment Comprehensive Study by Type (Keratosis Treatment, Addiction Treatment, Disease Treatment), Application (Hospitals & Clinics, Academic & Research Organizations, Pharmacies),... 
Via SBWire
Exposures Climate
FDA Nods to Pfizer's Paxlovid for COVID-19: A Potential $8 Billion Lifesaver in 2023
 
Via Benzinga
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
Benzinga 
Via Benzinga
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END 
Via FinancialNewsMedia
Can Pfizer Stock Double Your Money in 3 Years?
Wall Street may be overlooking the potential of the drugmaker's GLP-1 pipeline assets. 
Via The Motley Fool
Pfizer Unusual Options Activity
 
Via Benzinga
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Tuesday Trading
Via Investor Brand Network
Exposures COVID-19
Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases
 
Via Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
 
Via Benzinga
Why Pfizer Stock Slipped by 2% Today
The market wasn't impressed by the company's latest drug approval, plus an analyst cut her price target on the shares. 
Via The Motley Fool
Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall
Value stocks fell to a seven-month low in relation to growth stocks, already lagging by more than 20% year to date on the heels of an AI-related rally propelling equities in the technology sector.  
Via Benzinga
Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting
From Pfizer Inc.
Via Business Wire
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
In an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains in line with... 
Via Benzinga
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
These companies haven't given up on the coronavirus vaccine market. 
Via The Motley Fool
Most Active Equity Options For Midday - Thursday, May 25
Via Talk Markets
7 Top Stock Tips for June 2023
The stock market remains unpredictable and volatile. As such, investors should be aware of the following top stock tips for the second half. 
Via InvestorPlace
Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
From Pfizer Inc.
Via Business Wire
Pfizer Has the Prescription for Higher Share Prices
Pfizer's 4% yield is more attractive than ever after positive results from a study and an upgrade from Cantor Fitzgerald. 
Via MarketBeat
Topics Derivatives Intellectual Property
Exposures Derivatives Intellectual Property
Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside
 
Via Benzinga
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results
 
Via Benzinga
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M
 
Via Benzinga
Why Novavax, Pfizer And BioNTech Shares Are Rising Today
Shares of vaccine makers Novavax Inc (NASDAQ: NVAX), Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) a 
Via Benzinga
Worried About a Recession? 2 Safe Stocks to Buy Now
These stocks have what it takes to remain strong during tough economic times and beyond. 
Via The Motley Fool
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Should Pfizer and Seagen investors be worried? 
Via The Motley Fool
Most Active Equity Options For Midday - Tuesday, May 23
Here are the most active equity options for midday. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.